Suchergebnisse

3838 Artikel wurden gefunden.

Die folgenden Begriffe wurden einbezogen: cancer, Krebs, がん

• 2001, Mason PA, Walters TJ, DiGiovanni J, Beason CW, Jauchem JR, Dick Jr EJ, Mahajan K, Dusch SJ, Shields BA, Merritt JH, Murphy MR, Ryan KL
  [Details] Lack of effect of 94 GHz radio frequency radiation exposure in an animal model of skin carcinogenesis [med./bio.]
  Carcinogenesis 22 (10): 1701-1708
• 2001, Savitz DA
  Occupational exposure to magnetic fields and brain cancer [Kommentar]
  Occup Environ Med 58 (10): 617-618
• 2001, Sorahan T, Nichols L, van Tongeren M, Harrington JM
  Occupational exposure to magnetic fields relative to mortality from brain tumours: updated and revised findings from a study of United Kingdom electricity generation and transmission workers, 1973-97 [epidem.]
  Occup Environ Med 58 (10): 626-630
• 2001, Ding GR, Nakahara T, Tian FR, Guo Y, Miyakoshi J
  Transient suppression of X-ray-induced apoptosis by exposure to power frequency magnetic fields in MCF-7 cells [med./bio.]
  Biochem Biophys Res Commun 286 (5): 953-957
• 2001, Tofani S, Barone D, Cintorino M, de Santi MM, Ferrara A, Orlassino R, Ossola P, Peroglio F, Rolfo K, Ronchetto F
  [Details] Static and ELF magnetic fields induce tumor growth inhibition and apoptosis [med./bio.]
  Bioelectromagnetics 22 (6): 419-428
• 2001, Neel MD, Letson GD
  Modular endoprostheses for children with malignant bone tumors [med. Anw.]
  Cancer Control 8 (4): 344-348
• 2001, Supino R, Bottone MG, Pellicciari C, Caserini C, Bottiroli G, Belleri M, Veicsteinas A
  [Details] Sinusoidal 50 Hz magnetic fields do not affect structural morphology and proliferation of human cells in vitro [med./bio.]
  Histol Histopathol 16 (3): 719-726
• 2001, Simko M, Richard D, Kriehuber R, Weiss DG
  [Details] Micronucleus induction in Syrian hamster embryo cells following exposure to 50 Hz magnetic fields, benzo(a)pyrene, and TPA in vitro [med./bio.]
  Mutat Res Genet Toxicol Environ Mutagen 495 (1-2): 43-50
• 2001, Hardell L, Hansson Mild K
  Reply: Cellular telephones and cancer--a nationwide cohort study in Denmark [Kommentar]
  J Natl Cancer Inst 93 (12): 952-953
• 2001, De Roos AJ, Teschke K, Savitz DA, Poole C, Grufferman S, Pollock BH, Olshan AF
  Parental occupational exposures to electromagnetic fields and radiation and the incidence of neuroblastoma in offspring [epidem.]
  Epidemiology 12 (5): 508-517
• 2001, Schüz J, Michaelis J
  [Details] Epidemiologie nicht-ionisierender elektromagnetischer Felder - eine Übersicht [Review]
  Umweltmed Forsch Prax 6 (2): 67-76
• 2001, van Wijngaarden E, Nylander-French LA, Millikan RC, Savitz DA, Loomis D
  Population-based case-control study of occupational exposure to electromagnetic fields and breast cancer [epidem.]
  Ann Epidemiol 11 (5): 297-303
• 2001, Cabrales LB, Ciria HC, Bruzon RP, Quevedo MS, Aldana RH, De Oca LM, Salas MF, Od Pena
  Electrochemical treatment of mouse Ehrlich tumor with direct electric current [med. Anw.]
  Bioelectromagnetics 22 (5): 316-322
• 2001, Nordenson I, Hansson Mild K, Jarventaus H, Hirvonen A, Sandström M, Wilen J, Blix N, Norppa H
  Chromosomal aberrations in peripheral lymphocytes of train engine drivers [med./bio.]
  Bioelectromagnetics 22 (5): 306-315
• 2001, French PW, Penny R, Laurence JA, McKenzie DR
  Mobile phones, heat shock proteins and cancer [tech./dosim.]
  Differentiation 67 (4-5): 93-97
• 2001, Ishido M, Nitta H, Kabuto M
  Magnetic fields (MF) of 50 Hz at 1.2 microT as well as 100 microT cause uncoupling of inhibitory pathways of adenylyl cyclase mediated by melatonin 1a receptor in MF-sensitive MCF-7 cells [med./bio.]
  Carcinogenesis 22 (7): 1043-1048
• 2001, Graham C, Cook MR, Gerkovich MM, Sastre A
  Examination of the melatonin hypothesis in women exposed at night to EMF or bright light [med./bio.]
  Environ Health Perspect 109 (5): 501-507
• 2001, Park R
  Cellular telephones and cancer: How should science respond? [Sonst.]
  J Natl Cancer Inst 93 (3): 166-167
• 2001, Cooper D, Hemmings K, Saunders P
  Reply: "Cancer incidence near radio and television transmitters in Great Britain. I. Sutton Coldfield transmitter; II. All high power transmitters" [Kommentar]
  Am J Epidemiol 153 (2): 202-204
• 2001, de Bruyn L, de Jager L, Kuyl JM
  [Details] The influence of long-term exposure of mice to randomly varied power frequency magnetic fields on their nocturnal melatonin secretion patterns [med./bio.]
  Environ Res 85 (2): 115-121
• 2001, Minder CE, Pfluger DH
  Leukemia, brain tumors, and exposure to extremely low frequency electromagnetic fields in Swiss railway employees [epidem.]
  Am J Epidemiol 153 (9): 825-835
• 2001, Savitz DA
  Invited commentary: electromagnetic fields and cancer in railway workers [Kommentar]
  Am J Epidemiol 153 (9): 836-838
• 2001, Repacholi MH
  [Details] Health risks from the use of mobile phones [Review]
  Toxicol Lett 120 (1-3): 323-331
• 2001, Harada S, Yamada S, Kuramata O, Gunji Y, Kawasaki M, Miyakawa T, Yonekura H, Sakurai S, Bessho K, Hosono R, Yamamoto H
  [Details] Effects of high ELF magnetic fields on enzyme-catalyzed DNA and RNA synthesis in vitro and on a cell-free DNA mismatch repair [med./bio.]
  Bioelectromagnetics 22 (4): 260-266
• 2001, Schüz J, Grigat JP, Brinkmann K, Michaelis J
  [Details] Residential magnetic fields as a risk factor for childhood acute leukaemia: results from a German population-based case-control study [epidem.]
  Int J Cancer 91 (5): 728-735
• 2001, Zook BC, Simmens SJ
  [Details] The effects of 860 MHz radiofrequency radiation on the induction or promotion of brain tumors and other neoplasms in rats [med./bio.]
  Radiat Res 155 (4): 572-583
• 2001, Ren RL, Vora N, Yang F, Longmate J, Wang W, Sun H, Li JR, Weiss L, Staud C, McDougall JA, Chou CK
  Variations of dose and electrode spacing for rat breast cancer electrochemical treatment [med. Anw.]
  Bioelectromagnetics 22 (3): 205-211
• 2001, Anderson LE, Morris JE, Miller DL, Rafferty CN, Ebi KL, Sasser LB
  [Details] Large granular lymphocytic (LGL) leukemia in rats exposed to intermittent 60 Hz magnetic fields [med./bio.]
  Bioelectromagnetics 22 (3): 185-193
• 2001, Leman ES, Sisken BF, Zimmer S, Anderson KW
  Studies of the interactions between melatonin and 2 Hz, 0.3 mT PEMF on the proliferation and invasion of human breast cancer cells [med./bio.]
  Bioelectromagnetics 22 (3): 178-184
• 2001, Wartenberg D
  [Details] The potential impact of bias in studies of residential exposure to magnetic fields and childhood leukemia [Review]
  Bioelectromagnetics: S32-S47
• 2001, Pollan M, Gustavsson P, Floderus B
  Breast cancer, occupation, and exposure to electromagnetic fields among Swedish men [epidem.]
  Am J Ind Med 39 (3): 276-285
• 2001, Schüz J, Grigat JP, Brinkmann K, Michaelis J
  [Details] Childhood acute leukaemia and residential 16.7 Hz magnetic fields in Germany [epidem.]
  Br J Cancer 84 (5): 697-699
• 2001, Krewski D, Byus CV, Glickman BW, Lotz WG, Mandeville R, McBride ML, Prato FS, Weaver DF
  [Details] Potential health risks of radiofrequency fields from wireless telecommunication devices [Review]
  J Toxicol Environ Health B Crit Rev 4 (1): 1-143
• 2001, Krewski D, Byus CV, Glickman BW, Lotz WG, Mandeville R, McBride ML, Prato FS, Weaver DF
  [Details] Recent advances in research on radiofrequency fields and health [Review]
  J Toxicol Environ Health B Crit Rev 4 (1): 145-159
• 2001, Lin H, Blank M, Rossol-Haseroth K, Goodman R
  [Details] Regulating genes with electromagnetic response elements [med./bio.]
  J Cell Biochem 81 (1): 143-148
• 2001, Johansen C, Boice Jr JD, McLaughlin J, Olsen J
  [Details] Cellular telephones and cancer--a nationwide cohort study in Denmark [epidem.]
  J Natl Cancer Inst 93 (3): 203-207
• 2001, Jauchem JR, Ryan KL, Frei MR, Dusch SJ, Lehnert HM, Kovatch RM
  [Details] Repeated exposure of C3H/HeJ mice to ultra-wideband electromagnetic pulses: lack of effects on mammary tumors [med./bio.]
  Radiat Res 155 (2): 369-377
• 2001, Savitz DA, Poole C
  [Details] Do studies of wire code and childhood leukemia point towards or away from magnetic fields as the causal agent? [Review]
  Bioelectromagnetics: S69-S85
• 2001, Wartenberg D
  [Details] Residential EMF exposure and childhood leukemia: meta-analysis and population attributable risk [Review]
  Bioelectromagnetics: S86-104
• 2001, Erren TC
  A meta-analysis of epidemiologic studies of electric and magnetic fields and breast cancer in women and men [epidem.]
  Bioelectromagnetics: S105-S119
• 2001, Kheifets LI
  Electric and magnetic field exposure and brain cancer: a review [Review]
  Bioelectromagnetics: S120-S131
• 2001, Ahlbom A
  [Details] Neurodegenerative diseases, suicide and depressive symptoms in relation to EMF [Review]
  Bioelectromagnetics: S132-S143
• 2001, Neutra RR
  Panel exploring pro and con arguments as to whether EMFs cause childhood brain cancer [Sonst.]
  Bioelectromagnetics: S144-S149
• 2001, Lindgren M, Gustavsson M, Hamnerius Y, Galt S
  ELF magnetic fields in a city environment [tech./dosim.]
  Bioelectromagnetics 22 (2): 87-90
• 2001, Blackman CF, Benane SG, House DE
  [Details] The influence of 1.2 microT, 60 Hz magnetic fields on melatonin- and tamoxifen-induced inhibition of MCF-7 cell growth [med./bio.]
  Bioelectromagnetics 22 (2): 122-128
• 2001, Stang A, Anastassiou G, Ahrens W, Bromen K, Bornfeld N, Jöckel KH
  [Details] The possible role of radiofrequency radiation in the development of uveal melanoma [epidem.]
  Epidemiology 12 (1): 7-12
• 2000, Keine Autoren angegeben
  Safety Levels for Human Exposure: European Standards Cebec Registered Quality [temp.]
  EMC Europe 2000 Brugge, 4th European Symposium on Electromagnetic Compatibility, Brugge, Belgium. IEEE: S. 461-475
• 2000, Liu CJ, Wang B, Wang Z, Zhang H
  Cell deformation and increase of cytotoxicity of anticancer drugs due to low-intensity transient electromagnetic pulses [med./bio.]
  IEEE Trans Plasma Sci 28 (1): 150-154
• 2000, Shevchenko AI
  [The correction of the immune status at the postoperative rehabilitative stage in lung cancer patients by using millimeter-wave resonance therapy] [fremdsprachig]
  Lik Sprava (2): 95-97
• 2000, Nordenberg T
  Cell phones & cancer: No clear connection [Grundlagen]
  FDA Consum 34 (6): 19-23